5-aminosalicylates in inflammatory bowel disease and chronic renal failure: Authors' reply

被引:0
|
作者
Muller, AF [1 ]
Stevens, PE
McIntyre, AS
Ellison, H
Logan, RF
机构
[1] Kent & Canterbury Hosp, Dept Gastroenterol, Canterbury, Kent, England
[2] Kent & Canterbury Hosp, Dept Nephrol, Canterbury, Kent, England
[3] Wycombe Gen Hosp, Dept Med, Wycombe, Bucks, England
[4] British Soc Gastroenterol, London, England
[5] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England
关键词
D O I
10.1111/j.1365-2036.2005.02618.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:579 / 580
页数:2
相关论文
共 50 条
  • [41] Review article: aminosalicylates in inflammatory bowel disease
    Hanauer, SB
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 60 - 65
  • [42] Aminosalicylates in the treatment of children with inflammatory bowel disease
    Ferry, GD
    INFLAMMATORY BOWEL DISEASES, 1998, 4 (02) : 113 - 114
  • [43] The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease
    Klotz, U
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (05) : 353 - 362
  • [44] Effects of 5-aminosalicylates or thiopurines on the progression of low-grade dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Jian Zeng
    Zhang-Min Meng
    Xiao-Li Huang
    Hua-Tian Gan
    International Journal of Colorectal Disease, 2021, 36 : 11 - 18
  • [45] 5-Aminosalicylates to Prevent Relapse of Crohn's Disease After Surgery
    Doherty, Glen
    Moss, Alan C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (03): : 487 - 487
  • [46] 5-AMINOSALICYLATES FOR PREVENTION OF RECURRENCE IN PATIENTS WITH CROHNS-DISEASE - TIME FOR A REAPPRAISAL
    SUTHERLAND, LR
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1991, 13 (01) : 5 - 7
  • [47] SULFASALAZINE AND THE AMINOSALICYLATES IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    RILEY, SA
    TURNBERG, LA
    QUARTERLY JOURNAL OF MEDICINE, 1990, 75 (278): : 551 - 562
  • [48] Medication Adherence in Inflammatory Bowel Disease in the Global ALIGN Study: Impact of Concerns and Perceived Necessity of Immunosuppressants, 5-Aminosalicylates, and Tumor Necrosis Factor Inhibitors
    Nurwakagari, Pascal
    Michetti, Pierre
    Peyrin-Biroulet, Laurent
    Louis, Edouard
    Silverberg, Mark
    Weinman, John
    Sommer, Julia
    Petersson, Joel
    Pappalardo, Brandee
    Selenko-Gebauer, Nicole
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S795 - S795
  • [49] Editorial: anxiety and depression in inflammatory bowel disease - authors' reply
    Stapersma, Luuk
    van den Brink, Gertrude
    Szigethy, Eva M.
    Escher, Johanna C.
    Utens, Elisabeth M. W. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (06) : 687 - 688
  • [50] The changing epidemiology of paediatric inflammatory bowel disease: authors' reply
    Chouraki, V.
    Turck, D.
    Colombel, J. -F.
    Gower-Rousseau, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (12) : 1381 - 1382